cytokin
storm
viral
infect
prospect
predictor
morbid
mortal
yet
cellular
sourc
remain
undefin
use
genet
chemic
tool
probe
function
receptor
elucid
cellular
signal
mechan
import
initi
cytokin
storm
wherea
receptor
express
endotheli
cell
lymphocyt
within
lung
tissu
agon
suppress
cytokin
innat
immun
cell
recruit
wildtyp
lymphocytedefici
mice
identifi
endotheli
cell
central
regul
cytokin
storm
furthermor
data
reveal
immun
cell
infiltr
cytokin
product
distinct
event
orchestr
endotheli
cell
moreov
demonstr
suppress
earli
innat
immun
respons
signal
result
reduc
mortal
infect
human
pathogen
strain
influenza
viru
modul
endothelium
specif
agonist
suggest
diseas
amplif
cytokin
storm
signific
patholog
compon
could
chemic
tractabl
morbid
mortal
caus
sever
influenza
infect
reflect
properti
intrins
viru
strain
includ
replic
potenti
receptor
usag
cytopath
effect
pulmonari
epitheli
cell
tschern
addit
viralintrins
factor
hostspecif
trait
diverg
suscept
infect
well
differ
host
immun
respons
may
amelior
exacerb
infect
clinic
outcom
overli
aggress
innat
respons
earli
recruit
inflammatori
leukocyt
lung
key
contributor
morbid
influenza
infect
kobasa
et
al
recent
clinic
literatur
avian
infect
document
signific
associ
excess
earli
cytokin
respons
immun
cell
recruit
poor
outcom
de
jong
et
al
public
health
approach
influenza
pandem
reli
primarili
prevent
vaccin
strategi
support
measur
includ
use
antivir
therapi
nevertheless
speed
influenza
viru
swine
pandem
spread
lag
vaccin
avail
highlight
need
identifi
addit
mechan
amelior
influenza
viru
infect
openshaw
dun
antivir
drug
inhibit
viru
replic
may
select
mutat
escap
render
therapi
ineffect
modul
host
immun
respons
potenti
advantag
exert
lessselect
pressur
viral
popul
though
prospect
blunt
cytokin
storm
entic
major
limit
treat
diseas
cytokin
storm
contribut
pathogenesi
limit
understand
cellular
trigger
process
thu
sought
defin
cellular
signal
pathway
chemic
tractabl
test
hypothesi
modul
cytokin
storm
would
provid
insight
influenza
pathogenesi
potenti
therapeut
implic
chemic
modul
signal
system
provid
insight
immun
cell
traffick
immun
respons
rivera
et
al
rosen
et
al
due
immunomodulatori
properti
receptor
signal
chemic
agonist
use
success
treatment
relaps
remit
multipl
sclerosi
brinkmann
et
al
though
system
biolog
receptor
complex
five
receptor
subtyp
differenti
express
coupl
attenu
catabol
rosen
liao
avail
select
chemic
probe
togeth
mous
genet
model
allow
detail
insight
immunopathogenesi
previous
show
nonselect
receptor
agonist
inhibit
cytokin
storm
dendrit
cell
migrat
subsequ
antigenspecif
cell
prolifer
protect
lung
tissu
hostmedi
injuri
allevi
immunopatholog
nonselect
receptor
agonist
affect
viru
clearanc
product
neutral
antibodi
demonstr
although
cytokin
storm
diminish
retent
suffici
cellular
humor
immun
respons
well
longterm
protect
immun
still
occur
marsolai
et
al
use
receptor
subtypeselect
agonist
well
genet
biochem
tool
defin
crucial
endotheli
signal
loop
import
initi
cytokin
storm
reveal
cytokin
secret
immun
cell
infiltr
separ
event
regul
pulmonari
endothelium
demonstr
suppress
earli
innat
immun
respons
signal
result
reduc
mortal
human
pathogen
influenza
viru
challeng
thu
receptor
signal
endothelium
provid
mechan
attenu
influenza
virusinduc
morbid
reveal
unexpect
role
endotheli
cell
regul
cytokin
storm
administr
agonist
blunt
cytokin
storm
previous
report
treatment
influenza
virusinfect
mice
aalr
promiscu
receptor
agonist
receptor
inhibit
earli
proinflammatori
cytokin
express
innat
immun
cell
accumul
within
lung
marsolai
et
al
assess
contribut
receptor
signal
inhibit
influenza
virusinduc
earli
inflamm
infect
mice
treat
receptorspecif
agonist
gonzalezcabrera
et
al
treatment
mgkg
twice
daili
significantli
inhibit
secret
cytokin
chemokin
associ
influenza
virusinduc
patholog
includ
ifna
tnfa
ifng
figur
addit
figur
compar
vehicletr
mice
hr
postinfect
reduct
ifna
express
complet
treatment
promiscu
agonist
howev
effect
aalr
suppress
tnfa
ifng
figur
figur
suggest
role
receptor
modul
cytokin
addit
inhibit
cytokinechemokin
product
aalr
administr
influenza
virusinfect
mice
blunt
accumul
innat
inflammatori
infiltr
character
macrophagesmonocyt
neutrophil
nk
cell
although
aalr
effect
inhibit
macrophagemonocyt
nk
cell
accumul
lung
figur
also
observ
significantli
reduc
express
macrophagemonocyt
nk
cell
follow
treatment
either
aalr
hr
postinfect
demonstr
diminish
cell
activ
figur
despit
signific
blunt
innat
immun
cell
recruit
cytokinechemokin
respons
observ
differ
viral
titer
follow
aalr
treatment
compar
data
repres
averag
sem
four
mice
per
group
p
p
p
result
repres
greater
six
independ
experi
see
also
figur
figur
vehicletr
mice
figur
demonstr
agon
neither
inhibit
enhanc
viral
replic
collect
result
reveal
activ
singl
receptor
suffici
blunt
global
innat
inflamm
follow
mouseadapt
influenza
viru
infect
mice
next
ask
whether
receptor
agon
could
suppress
earli
innat
cytokin
chemokin
respons
follow
infect
human
pathogen
isol
influenza
viru
test
infect
mice
virul
isol
pandem
influenza
viru
isol
hospit
patient
never
passag
mice
itoh
et
al
infect
mice
strain
caus
sever
diseas
result
rapid
mortal
begin
day
postinfect
data
shown
similar
infect
mouseadapt
wsn
influenza
viru
treatment
follow
infect
significantli
suppress
cytokin
chemokin
respons
accumul
activ
innat
immun
cell
hr
postinfect
figur
also
test
addit
receptorselect
agonist
provid
support
receptor
specif
show
directli
agonist
share
modul
innat
immunopatholog
infect
mice
pandem
influenza
viru
treat
mice
hr
postinfect
similar
observ
treatment
significantli
inhibit
product
multipl
proinflammatori
cytokin
chemokin
figur
suppress
accumul
activ
macrophagesmonocyt
nk
cell
infect
lung
hr
postinfect
figur
moreov
suppress
innat
immun
cell
recruit
cytokinechemokin
product
occur
without
alter
lung
viral
titer
figur
demonstr
agonistmedi
suppress
cytokin
chemokin
due
direct
effect
influenza
viru
replic
agonistmedi
suppress
earli
innat
immun
respons
result
protect
human
pathogen
influenza
viru
challeng
mice
earli
dysregul
innat
immun
respons
lung
associ
morbid
mortal
infect
highli
pathogen
strain
influenza
viru
niz
et
al
kobasa
et
al
therefor
ask
whether
blunt
earli
innat
cytokinechemokin
respons
use
agonist
could
protect
mice
lethal
infect
virul
human
isol
pandem
passag
mice
order
impos
addit
stress
infect
lung
oral
deliveri
popular
rout
drug
administr
oral
administ
agonist
mgkg
gavag
mice
infect
pfu
figur
earli
administr
result
enhanc
surviv
time
lethal
challeng
death
initi
vehicletr
mice
day
postinfect
compar
day
postinfect
mice
figur
p
moreov
treatment
result
signific
improv
overal
surviv
compar
vehicletr
mice
mortal
versu
mortal
vehicl
p
figur
find
demonstr
signific
biolog
phenotyp
result
earli
receptor
agonist
treatment
follow
pathogen
influenza
viru
infect
show
directli
abort
earli
step
cytokin
amplif
significantli
protect
ordinarili
lethal
human
pathogen
infect
find
expand
previou
observ
associ
human
anim
model
dysregul
innat
immun
respons
contribut
morbid
mortal
importantli
treatment
amelior
morbid
mortal
associ
human
pathogen
sever
influenza
infect
effect
upon
surviv
keep
previous
publish
data
marsolai
et
al
mechan
alter
virusspecif
neutral
antibodi
respons
affin
matur
class
switch
document
cytokin
storm
play
direct
cardin
role
influenzamedi
lung
diseas
sought
delin
mechan
suppress
cytokin
amplif
identifi
cell
lung
express
receptor
util
receptor
knockin
mous
nativ
receptor
homolog
replac
function
enhanc
green
fluoresc
protein
egfp
tag
receptor
egfp
cahalan
et
al
mous
model
allow
direct
detect
receptor
protein
express
flow
cytometri
addit
biochem
confirm
use
highli
specif
antibodi
gfp
follow
western
blot
distinguish
fuse
egfp
receptor
specif
molecular
weight
high
level
egfp
detect
lung
lymphat
vascular
endothelium
wherea
pulmonari
epithelium
epcam
neg
egfp
figur
report
previous
cell
cell
b
cell
express
egfp
figur
wherea
leukocyt
includ
macrophagesmonocyt
subset
alveolar
macrophag
dendrit
cell
iaie
neutrophil
nk
cell
innat
lymphoid
cell
lin
express
neglig
level
egfp
figur
data
shown
cell
uninfect
mice
express
similar
level
egfp
infect
mice
demonstr
receptor
express
alter
follow
influenza
viru
infect
figur
confirm
egfp
express
pattern
western
blot
egfp
perform
cell
fac
sort
lung
infect
data
repres
averag
sd
two
five
mice
per
group
result
repres
three
independ
experi
see
also
figur
uninfect
mice
endotheli
cell
cell
b
cell
posit
egfp
uninfect
mice
confirm
flow
cytometri
result
figur
howev
though
egfp
detect
western
blot
b
cell
uninfect
mice
detect
egfp
express
western
blot
influenza
virusinfect
lungresid
b
cell
figur
detect
express
western
blot
epitheli
cell
macrophagesmonocyt
alveolar
macrophag
either
influenza
viru
infect
figur
moreov
treatment
infect
egfp
knockin
mice
diminish
express
egfp
endotheli
cell
cell
b
cell
demonstr
administr
specif
agonist
induc
degrad
receptor
figur
therefor
exert
antagonist
effect
due
receptor
degrad
demonstr
function
agon
mechan
suppress
cytokin
storm
inhibit
cytokin
storm
due
lymphocyt
receptor
activ
lymphocyt
pulmonari
endothelium
cell
within
lung
express
measur
amount
egfp
detect
flow
cytometri
western
blot
plausibl
lymphocyt
within
lung
provid
bystand
effect
innat
immun
respons
influenza
viru
infect
rule
role
lymphocyt
receptormedi
inhibit
inflamm
follow
influenza
viru
infect
lymphocytedefici
mice
infect
treat
vehicl
administr
influenza
virusinfect
mice
result
signific
inhibit
express
ifna
tnfa
ifng
figur
addit
figur
atyp
lymphocyt
popul
could
princip
contribut
suppress
cytokin
product
express
thu
also
contribut
mechan
inflammatori
cell
infiltr
includ
macrophagesmonocyt
nk
cell
significantli
reduc
mice
figur
reduc
number
neutrophil
also
observ
within
infect
lung
differ
statist
signific
figur
moreov
lunginfiltr
macrophag
nk
cell
mice
less
activ
measur
surfac
express
figur
treatment
influenza
virusinfect
lymphocytedefici
mice
inhibit
innat
inflammatori
respons
exclud
role
lymphocyt
key
regul
influenza
virusinduc
cytokin
storm
strong
express
egfp
receptor
pulmonari
endothelium
coupl
inhibit
cytokin
storm
mice
suggest
receptor
signal
lung
endotheli
cell
suppress
cytokin
storm
endotheli
cell
shown
produc
variou
cytokin
chemokin
inflammatori
process
may
sourc
cytokin
chemokin
lung
influenza
viru
infect
evalu
effect
treatment
pulmonari
endotheli
cell
cytokin
chemokin
product
purifi
lung
endotheli
cell
popul
perform
mrna
protein
analys
endotheli
cell
express
elev
level
chemokin
mrna
level
figur
importantli
treatment
significantli
reduc
mrna
express
chemokin
lung
endotheli
cell
compar
vehicletr
mice
earli
influenza
viru
infect
figur
examin
chemokin
product
purifi
lung
vascular
lymphat
endotheli
cell
reveal
signific
reduct
chemokin
product
protein
level
treatment
figur
analysi
pulmonari
endotheli
cell
integrin
express
show
appreci
differ
mice
infect
influenza
viru
treat
vehicl
compar
figur
chemokin
present
endotheli
cell
crucial
leukocyt
activ
extravas
infect
tissu
ask
whether
reduct
chemokin
express
follow
treatment
result
reduc
entri
inflammatori
cell
infect
lung
experi
data
repres
averag
sem
five
mice
per
group
p
p
p
result
repres
two
independ
experi
see
also
figur
figur
data
repres
averag
sem
five
micegroup
p
p
p
result
repres
two
independ
experi
see
also
figur
figur
use
lysmgfp
mice
macrophag
monocyt
neutrophil
express
green
fluoresc
protein
allow
us
track
cell
popul
adopt
transfer
congen
mice
infect
lysmgfp
mice
influenza
viru
hr
later
purifi
bone
marrow
cell
adopt
transfer
lysmgfp
bone
marrow
cell
transfer
influenza
virusinfect
mice
treat
either
vehicl
figur
lung
infect
uninfect
mice
receiv
lysmgfp
cell
harvest
hr
postinfect
number
gfpposit
cell
lung
quantifi
treatment
result
significantli
reduc
recruit
gfpposit
neutrophil
macrophag
monocyt
lung
figur
therefor
treatment
inhibit
infiltr
circul
inflammatori
cell
lung
receptor
signal
associ
enhanc
capillari
integr
rosen
et
al
wherebi
receptor
antagonist
induc
vascular
leakag
sanna
et
al
agonist
protect
vascular
leakag
induc
exogen
administr
vegf
sanchez
et
al
though
myelomonocyt
recruit
modul
endotheli
permeabl
chang
formal
assess
whether
suppress
inflammatori
cell
recruit
lung
reflect
passiv
inhibit
leukocyt
recruit
whether
suppress
chemokin
lung
endotheli
cell
limit
innat
immun
cell
recruit
rescu
experi
perform
mice
infect
influenza
presenc
absenc
intratrach
administr
recombin
murin
without
treatment
administr
infect
mice
treat
restor
macrophagemonocyt
nk
cell
number
lung
level
equival
infect
mice
treat
vehicl
figur
hr
postinfect
data
demonstr
inhibit
cellular
infiltr
lung
due
enhanc
endotheli
cell
barrier
function
due
suppress
chemokin
product
therefor
receptor
agon
suppress
endotheli
cell
chemokin
express
result
diminish
cell
infiltr
despit
rescu
level
balf
restor
macrophagemonocyt
recruit
lung
mice
global
cytokin
chemokin
product
restor
figur
figur
influenza
viru
infect
mice
result
substanti
reduct
infiltr
macrophagesmonocyt
dawson
et
al
rule
infiltr
macrophag
infect
mice
wsn
influenza
viru
done
treat
either
vehicl
infect
mice
result
significantli
reduc
number
macrophagesmonocyt
without
alter
neutrophil
nk
cell
number
lung
hr
postinfect
figur
despit
reduc
level
macrophagesmonocyt
lung
still
detect
signific
level
ifna
ifng
figur
importantli
treatment
mice
still
significantli
reduc
cytokin
chemokin
test
hr
postinfect
except
figur
failur
inhibit
cytokin
chemokin
product
mice
reestablish
cytokin
chemokin
product
induct
macrophagemonocyt
cell
infiltr
administr
follow
treatment
suggest
monocyt
macrophag
major
sourc
earli
cytokin
chemokin
product
furthermor
data
indic
cell
recruit
cytokin
respons
may
uncoupl
event
infiltr
macrophag
nk
cell
alon
appear
associ
cytokin
storm
therefor
evalu
contribut
total
inflammatori
cell
infiltr
cytokin
product
influenza
viru
infect
mice
treat
antibodi
shown
inhibit
recruit
cell
inflam
tissu
rosen
gordon
though
treatment
significantli
inhibit
recruit
macrophag
monocyt
neutrophil
nk
cell
lung
figur
observ
reduct
level
proinflammatori
cytokineschemokin
ifng
figur
probabl
direct
result
diminish
infiltr
nk
cell
primari
sourc
ifng
time
point
moreov
treatment
significantli
inhibit
product
ifna
tnfa
ifng
figur
addit
figur
mice
result
demonstr
innat
cell
recruit
cytokin
product
independ
event
earli
influenza
viru
infect
inhibit
receptor
agon
pulmonari
endotheli
cell
importantli
data
demonstr
inflammatori
cell
infiltr
lung
requir
cytokin
chemokin
product
addit
line
evid
exclud
hematopoiet
cell
agonistmedi
reduct
earli
innat
cytokin
chemokin
respons
follow
influenza
viru
infect
provid
irradi
resist
agonist
suppress
mice
irradi
rad
hr
later
infect
wsn
influenza
viru
treat
either
vehicl
irradi
reduc
hematopoiet
cell
lung
vehicl
celllung
versu
rad
cellslung
importantli
treatment
irradi
mice
significantli
reduc
level
ifna
irradi
vehicl
pgml
versu
irradi
pgml
p
irradi
vehicl
pgml
versu
irradi
pgml
p
irradi
vehicl
pgml
versu
irradi
pgml
p
irradi
vehicl
pgml
versu
irradi
pgml
p
demonstr
radiationresist
cell
popul
mediat
receptormedi
suppress
inflammatori
respons
result
coupl
restrict
receptor
express
pattern
support
import
role
endotheli
cell
regul
pulmonari
innat
immun
respons
influenza
viru
type
interferon
predominantli
ifna
speci
elev
earli
respiratori
viru
infect
thought
crucial
product
proinflammatori
cytokin
chemokin
result
thu
far
demonstr
treatment
consist
inhibit
product
ifna
lung
earli
influenza
viru
infect
figur
figur
figur
figur
therefor
postul
blunt
ifna
product
may
mechan
inhibit
cytokin
storm
earli
influenza
viru
infect
address
infect
ifnab
receptor
knockout
mice
influenza
viru
treat
mice
either
vehicl
measur
innat
cell
recruit
cytokinechemokin
product
hr
postinfect
signific
differ
observ
inflammatori
cell
recruit
macrophag
monocyt
neutrophil
nk
cell
lung
ifnab
receptordefici
mice
compar
mice
figur
seen
infect
mice
treatment
inhibit
innat
immun
cell
recruit
ifnab
receptordefici
mice
hr
postinfect
figur
despit
recruit
innat
immun
cell
lung
ifnab
receptordefici
mice
hr
postinfect
mice
exhibit
significantli
reduc
level
ifna
ifng
figur
addit
balf
fluid
figur
taken
togeth
data
demonstr
regul
cellular
recruit
pulmonari
tissu
mediat
endotheli
cell
independ
type
interferon
signal
moreov
receptor
agon
endotheli
cell
inhibit
ifna
product
result
dampen
global
proinflammatori
cytokin
respons
recruit
innat
immun
cell
lung
combin
excess
proinflammatori
cytokin
chemokin
product
hallmark
influenza
viru
infect
la
gruta
et
al
contrari
current
dogma
place
lung
epithelium
inflammatori
infiltr
center
influenza
virusinduc
cytokin
storm
la
gruta
et
al
demonstr
central
role
pulmonari
endothelium
regul
process
furthermor
determin
innat
immun
cell
recruit
earli
innat
cytokin
chemokin
product
uncoupl
event
endotheli
cell
center
process
chemic
genet
approach
shown
potenti
broad
impact
data
repres
averag
sem
five
mice
per
group
p
p
p
result
repres
two
independ
experi
see
also
figur
figur
understand
diseas
pathogenesi
earli
dysregul
innat
cellular
cytokin
respons
predict
diseas
sever
death
highli
pathogen
influenza
viru
infect
bermejomartin
et
al
niz
et
al
de
jong
et
al
kobasa
et
al
kobasa
et
al
earli
induct
cytokin
ifna
tnfa
chemokin
associ
symptom
format
human
hayden
et
al
kaiser
et
al
tnfa
possess
multifunct
activ
associ
morbid
influenza
viru
infect
chemokin
induc
recruit
innat
immun
cell
lung
releas
cytokin
exacerb
cytokin
storm
damag
lung
demonstr
suppress
earli
innat
immun
respons
signal
endotheli
cell
result
significantli
reduc
mortal
infect
mice
human
pathogen
strain
influenza
viru
figur
importantli
result
identifi
pulmonari
cell
type
endotheli
cell
potenti
target
suppress
excess
innat
inflammatori
respons
abil
diminish
product
ifna
earli
follow
influenza
viru
infect
broadli
relev
requir
type
interferon
signal
earli
product
multipl
cytokin
chemokin
influenza
viru
infect
strike
moreov
product
proinflammatori
cytokin
requir
type
interferon
signal
type
interferon
pathway
dispens
cell
recruit
though
type
interferon
signal
well
known
inhibit
viral
replic
biron
evid
also
point
pathogen
role
ifna
viral
infect
sever
proinflammatori
cytokin
chemokin
downstream
type
interferon
receptor
signal
moreov
diseas
onset
correl
directli
local
respiratori
product
ifna
human
hayden
et
al
thu
type
interferon
signal
may
play
dual
role
viral
pathogenesi
viral
clearanc
receptor
signal
pulmonari
endotheli
cell
vivo
blunt
abolish
ifna
product
may
explain
patholog
lessen
without
compromis
host
abil
clear
viru
abil
receptor
activ
suppress
cytokin
chemokin
product
lung
irradi
mice
coupl
pattern
receptor
express
lung
strongli
indic
central
endotheli
compon
earli
innat
immun
respons
interest
question
whether
lung
lymphat
vascular
endotheli
cell
popul
directli
respons
observ
immun
modul
moreov
larg
receptor
reserv
blood
endothelium
ensur
receptor
express
maintain
basolater
lumin
surfac
target
endotheli
cell
popul
cahalan
et
al
retain
respons
agonist
addit
approach
separ
blood
lymphat
contribut
still
need
though
know
endotheli
cell
produc
chemokin
endothelialmedi
regul
cytokin
product
lung
still
need
determin
possibl
endotheli
cell
may
regul
cytokin
product
lung
complex
crosstalk
mechan
lung
epithelium
resid
hematopoiet
cell
nevertheless
identif
endotheli
cell
central
orchestr
earli
innat
immunemedi
inflamm
fundament
interest
broad
implic
treat
multipl
diseas
contribut
aberr
proinflammatori
cytokin
chemokin
product
pathogenesi
report
viral
bacteri
diseas
includ
hiv
stacey
et
al
hantaviru
borg
et
al
sever
acut
respiratori
syndrom
sar
thiel
weber
pneumococc
bacteri
pneumonia
bergeron
et
al
etiolog
sever
autoimmun
condit
directli
associ
excess
innat
immun
respons
kawan
et
al
link
thu
understand
cellular
pathway
regul
cytokin
storm
develop
appropri
chemic
signal
tool
identifi
pathophysiolog
point
control
provid
insight
microbialhost
interact
also
may
ultim
reveal
addit
approach
achiev
effect
immunotherapi
multipl
diseas
addit
result
present
nonlymphopen
mechan
sphingosin
analog
treatment
suppress
pathogen
immun
respons
lastli
data
suggest
endogen
act
endotheli
receptor
could
neg
regul
cytokin
amplif
rais
possibl
heterogen
metabol
individu
could
contribut
advantag
disadvantag
confer
genet
individu
host
surviv
number
diseas
sixto
eightweekold
male
mice
egfp
mice
describ
elsewher
cahalan
et
al
bred
maintain
close
breed
facil
scripp
research
institut
influenza
wsn
human
isol
kind
gift
yoshihiro
kawaoka
univers
madison
wi
amplifi
plaqu
madindarbi
canin
kidney
mdck
cell
mice
infect
intratrach
pfu
influenza
viru
intranas
pfu
isofluran
anesthesia
hr
postinfect
mice
anesthet
isofluran
inhal
deliveri
vehicl
ul
water
aalr
mgkg
dissolv
water
mgkg
dissolv
water
mgkg
mgkg
oral
dissolv
water
multipl
dose
compound
administ
specif
time
list
figurt
legend
aalr
synthes
accord
publish
method
jo
et
al
r
n
ndimethylacetamid
hydrochlorid
synthes
accord
publish
method
martinborough
et
al
compound
ec
nm
select
versu
select
versu
respect
assay
describ
cahalan
et
al
recombin
murin
purchas
shenandoah
biotechnolog
inc
warwick
pa
trachea
euthan
mice
expos
transect
incub
blunt
gaug
needl
one
millilit
phosphatebuff
salin
supplement
complet
mini
edtafre
proteas
inhibitor
cocktail
roch
infus
recov
four
time
recov
bronchoalveolar
lavag
fluid
spun
g
min
c
store
c
use
multiplex
elisa
perform
supernat
quansi
bioscienc
logan
ut
detect
tnfa
gmcsf
ifng
rant
elisa
also
perform
use
rant
tnfa
ifng
duoset
kit
r
system
well
verikin
mous
interferonalpha
interferonbeta
elisa
kit
pestka
biomed
laboratori
inc
quantif
mrna
chemokin
express
lung
endotheli
cell
fac
purifi
puriti
mrna
purifi
use
rneasi
mini
kit
qiagen
prior
realtim
pcr
genom
dna
digest
cdna
made
use
rt
first
strand
kit
accord
manufactur
instruct
sa
bioscienc
frederick
md
cdna
ng
ad
individu
well
quantifi
use
rt
profil
pcr
array
accord
manufactur
instruct
sa
bioscienc
frederick
md
lung
harvest
pbsperfus
mice
mechan
dice
small
tissu
piec
use
surgic
scissor
dice
lung
suspend
ml
cdti
buffer
mgml
collagenas
clostridium
histolyticum
type
iv
sigma
mgml
dnase
bovin
pancrea
grade
ii
roch
mgml
trypsin
inhibitor
type
ii
sigma
dmem
hr
c
lung
disrupt
mechan
mm
filter
red
blood
cell
lyse
use
red
blood
cell
lysi
buffer
trishcl
nh
cl
inflammatori
cell
purifi
centrifug
pbsbuffer
percol
ge
healthcar
life
scienc
rpm
min
cell
pellet
resuspend
stain
buffer
fc
receptor
block
use
mgml
antimous
bd
bioscienc
cell
stain
follow
antimous
antibodi
alexafluor
ebiosci
clone
peconjug
biolegend
inc
clone
apcconjug
ebiosci
clone
epcam
biolegend
inc
clone
pacif
blueconjug
biolegend
inc
clone
bd
bioscienc
clone
ebiosci
clone
ebiosci
clone
peconjug
bd
bioscienc
clone
pacif
blueconjug
bd
bioscienc
clone
peconjug
bd
bioscienc
clone
ebiosci
clone
ebiosci
clone
apcconjug
bd
bioscienc
clone
pacif
blue
peconjug
bd
bioscienc
clone
apcconjug
ebiosci
clone
peconjug
abd
serotec
clone
peconjug
iaie
bd
bioscienc
clone
conjug
ebiosci
clone
fitcconjug
bd
bioscienc
clone
apcconjug
ebiosci
clone
flow
cytometri
acquisit
perform
bd
facsdivadriven
bd
lsr
ii
flow
cytomet
becton
dickinson
compani
data
analyz
flowjo
softwar
treestar
inc
facspurifi
lung
cell
popul
cell
use
antibodi
describ
homogen
ripa
buffer
supplement
proteas
inhibitor
pierc
lysat
centrifug
g
min
protein
concentr
supernat
determin
bca
assay
pierc
equal
amount
protein
cell
lystat
load
nondenatur
condit
separ
sdspage
nupag
novex
bistri
gel
gel
transfer
pvdf
membran
follow
probe
gfp
use
antigfp
antibodi
abcam
antirabbit
ig
lightchain
hrp
secondari
elc
bioscienc
use
chemiluminesc
autoradiographi
figur
agon
suppress
innat
immun
cell
activ
follow
influenza
infect
lymphocytedefici
mice
relat
figur
mean
fluoresc
intens
express
quantifi
vehicl
treat
macrophagesmonocyt
nk
cell
mice
hr
postinfluenza
viru
infect
flow
cytometri
stain
data
repres
averag
sem
repres
micegroup
p
p
result
repres
two
independ
experi
data
repres
averag
sem
micegroup
p
p
p
result
repres
two
independ
experi
